↑ トップへ ← 戻る

 Drug(薬物リスト) DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

85 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   1) inosine 5'-monophosphate   Inosine   D00054   -   -   1件:
17 
 2   1-(2-isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d] pyrimidin-4-one   -   -   -   -   1件:
17 
 3   Adjuvant without active component   -   -   -   -   2件:
6,
17 
 4   Affitope® pd01a + adjuvant   -   -   -   -   2件:
6,
17 
 5   Affitope® pd03a + adjuvant   -   -   -   -   1件:
17 
 6   Angiotensin   Angiotensin ii   D00150, D02014   2件: AGTR1, AGTR2   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   7件:
17,
19,
46,
66,
86,
222,
224 
 7   Angiotensin-(1-7)   Angiotensin ii   D00150, D02014   2件: AGTR1, AGTR2   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   1件:
17 
 8   Anti-parkinson medication   -   -   -   -   4件:
5,
6,
7,
17 
 9   Autologous mesenchymal stem cells   -   -   -   -   5件:
2,
6,
13,
17,
46 
 10   Azd3241   -   -   -   -   2件:
6,
17 
 11   Azd3241 100mg   -   -   -   -   1件:
17 
 12   Azd3241 300mg   -   -   -   -   1件:
17 
 13   Azilect   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   3件:
5,
6,
17 
 14   Botulinum toxin type a   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   10件:
2,
5,
6,
7,
13,
15,
17,
70,
113,
149 
 15   Bq123   Bq123   -   -   -   1件:
17 
 16   Captopril   Captopril   D00251   1件: ACE   4件: Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system   2件:
17,
86 
 17   Carbidopa   Carbidopa   D00558   1件: DDC   9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   8件:
2,
4,
6,
13,
17,
90,
164,
201 
 18   Carbonate   Carbonate ion   -   -   -   10件:
2,
13,
17,
19,
46,
75,
96,
127,
235,
299 
 19   Cs10br05   -   -   -   -   1件:
17 
 20   Domperidone   Domperidone   D01745, D07868   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   5件:
6,
13,
17,
51,
230 
 21   Dops   Droxidopa   D01277   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   2件:
6,
17 
 22   Droxidopa   Droxidopa   D01277   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   3件:
5,
6,
17 
 23   Egcg   Epigallocatechin gallate   -   -   -   8件:
6,
13,
17,
28,
85,
113,
206,
299 
 24   Entacapone   Entacapone   D00781   1件: COMT   4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism   2件:
6,
17 
 25   Fipamezole   Fipamezole   -   -   -   2件:
6,
17 
 26   Fipamezole hydrochloride   Fipamezole   -   -   -   2件:
6,
17 
 27   Fipamezole hydrochloride 30 mg oral disintegrating tablets   Fipamezole   -   -   -   2件:
6,
17 
 28   Fipamezole hydrochloride 60 mg oral disintegrating tablets   Fipamezole   -   -   -   2件:
6,
17 
 29   Fipamezole hydrochloride 90 mg oral disintegrating tablets   Fipamezole   -   -   -   2件:
6,
17 
 30   Fludrocortisone   Fludrocortisone   D00986, D07967   1件: NR3C2   1件: Aldosterone-regulated sodium reabsorption   3件:
6,
17,
81 
 31   Flumazenil   Flumazenil   D00697   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   5件:
6,
13,
17,
18,
206 
 32   Fluoxetine   Fluoxetine   D00326, D00823   1件: SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   4件:
13,
17,
78,
86 
 33   Fluoxétine   -   -   -   -   1件:
17 
 34   Flutemetamol   Flutemetamol   -   -   -   5件:
5,
6,
7,
17,
127 
 35   Green tea   Green tea leaf   D06903   -   -   5件:
6,
17,
28,
46,
96 
 36   Green tea leaf   Green tea leaf   D06903   -   -   1件:
17 
 37   Hydrogen   Hydrogen   -   -   -   5件:
5,
6,
17,
97,
226 
 38   Inosine   Inosine   D00054   -   -   4件:
2,
6,
13,
17 
 39   Intranasal insulin   -   -   -   -   2件:
6,
17 
 40   Intravenous immunoglobulin   Immune globulin human   -   -   -   16件:
2,
11,
14,
17,
18,
35,
38,
39,
49,
51,
63,
65,
85,
164,
296,
309 
 41   Intravenous immunoglobulin (ivig)   Immune globulin human   -   -   -   4件:
14,
17,
164,
296 
 42   Intravesical injection of botulinum a toxin   -   -   -   -   2件:
6,
17 
 43   Iupac name: 1-(2-isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d] pyrimidin-4-one   -   -   -   -   1件:
17 
 44   Ivig   Immune globulin human   -   -   -   12件:
11,
13,
14,
17,
18,
50,
51,
63,
65,
85,
164,
296 
 45   Jp-1730/f01   -   -   -   -   2件:
6,
17 
 46   Jp-1730/f02   -   -   -   -   2件:
6,
17 
 47   Jp-1730/f03   -   -   -   -   2件:
6,
17 
 48   L-threo dops   Droxidopa   D01277   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
17 
 49   Levodopa   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   7件:
2,
4,
6,
17,
90,
164,
201 
 50   Levodopa test   Levodopa   D00059   5件: DRD1, DRD2, DRD3, DRD4, DRD5   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
17 
 51   Lithium carbonate   Lithium carbonate   D00801   -   -   5件:
2,
13,
17,
19,
127 
 52   Losartan   Losartan   D00357, D08146   1件: AGTR1   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   18件:
13,
17,
19,
46,
58,
66,
67,
85,
96,
97,
98,
113,
164,
167,
179,
215,
222,
299 
 53   Metoprolol   Metoprolol   D00601, D02358, D05011   1件: ADRB1   10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   6件:
17,
57,
58,
113,
193,
226 
 54   Metoprolol tartrate 50 mg   Metoprolol   D00601, D02358, D05011   1件: ADRB1   10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
17 
 55   Midodrine   Midodrine   D01307, D08220   3件: ADRA1A, ADRA1B, ADRA1D   7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   3件:
6,
17,
58 
 56   Nebivolol   Nebivolol   D05127   1件: ADRB1   10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   3件:
17,
113,
167 
 57   Nebivolol 5 mg   Nebivolol   D05127   1件: ADRB1   10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
17 
 58   Nitrogen   Nitrogen   D00083   -   -   5件:
5,
6,
17,
211,
299 
 59   Normal saline   -   -   -   -   14件:
6,
17,
22,
36,
46,
49,
60,
94,
96,
211,
226,
276,
296,
299 
 60   Nt 101   -   -   -   -   4件:
5,
6,
7,
17 
 61   Prozac   Fluoxetine   D00326, D00823   1件: SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   1件:
17 
 62   Pseudoephedrine   Pseudoephedrine   D00485, D05648, D05649, D08449   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
17 
 63   Pseudoephedrine + 480 ml water   Pseudoephedrine   D00485, D05648, D05649, D08449   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
17 
 64   Pseudoephedrine + 50 ml water   Pseudoephedrine   D00485, D05648, D05649, D08449   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
17 
 65   Raclopride   Raclopride   -   -   -   4件:
5,
6,
7,
17 
 66   Rasagiline   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   4件:
2,
5,
6,
17 
 67   Rasagiline mesylate   Rasagiline   D02562, D08469, D10829   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   2件:
6,
17 
 68   Rifampicin   Rifampicin   D00211   -   -   4件:
6,
17,
46,
299 
 69   Riluzole   Riluzole   D00775   14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway   7件:
2,
3,
5,
8,
13,
17,
206 
 70   Rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 71   Safinamide   Safinamide   D10158   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   2件:
6,
17 
 72   Safinamide methanesulfonate   Safinamide   D10158   1件: MAOB   13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism   2件:
6,
17 
 73   Saline   Sodium chloride   D02056   -   -   10件:
6,
13,
17,
53,
67,
78,
86,
97,
168,
299 
 74   Sildenafil25 mg   -   -   -   -   1件:
17 
 75   Sirolimus   Sirolimus   D00753   1件: MTOR   43件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway   30件:
13,
17,
34,
35,
36,
46,
51,
60,
62,
63,
65,
66,
67,
85,
89,
96,
98,
137,
157,
158,
192,
222,
277,
278,
279,
280,
281,
283,
285,
331 
 76   Sirolimus 2 mg   Sirolimus   D00753   1件: MTOR   43件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway   1件:
17 
 77   Sunphenon egcg   Epigallocatechin gallate   -   -   -   3件:
13,
17,
113 
 78   Td-9855   -   -   -   -   2件:
6,
17 
 79   Tea leaf   Tea leaf   -   -   -   1件:
17 
 80   Tllsh2910   -   -   -   -   1件:
17 
 81   Trimethaphan   Trimethaphan   D00612   1件: CHRNA10   1件: Neuroactive ligand-receptor interaction   1件:
17 
 82   Ubiquinol   Ubiquinol   -   -   -   3件:
6,
8,
17 
 83   Verdiperstat   Verdiperstat   D11684   1件: MPO   4件: Acute myeloid leukemia, Drug metabolism - other enzymes, Phagosome, Transcriptional misregulation in cancer   1件:
17 
 84   Water   Water   D00001   -   -   18件:
2,
5,
6,
13,
17,
19,
35,
46,
53,
57,
63,
65,
67,
84,
97,
226,
278,
299 
 85   Xeomin   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   7件:
5,
6,
7,
13,
15,
17,
113 

先頭へ